First patient enrolled into phase I/II clinical trial of NY-ESO-1・siTCR gene therapy against synovial sarcoma in Japan

2018 2018/01/19 First patient enrolled into phase I/II clinical trial of NY-ESO-1・siTCR gene therapy against synovial sarcoma in Japan Kusatsu/Shiga, Japan — January 17, 2018 — Takara Bio Inc. (Takara Bio), today announced that the first patient with synovial sarcoma has been enrolled into NY-ESO-1・siTCR gene therapy (TBI-1301) phase I/II clinical trial in Japan on January... Read more

Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology

Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology Industry-leading amplicon solution facilitates targeted next-generation sequencing in multiple application areas Thermo Fisher Scientific and Illumina, Inc.(NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct... Read more

Thermo Fisher Scientific Expands Oncomine Portfolio for Liquid Biopsy and Immuno-oncology Clinical Research

Thermo Fisher Scientific Expands Oncomine Portfolio for Liquid Biopsy and Immuno-oncology Clinical Research New pan-cancer cell-free total nucleic acid (cfTNA) assay and FFPE-based tumor mutation load analysis assay, coupled with novel Ion AmpliSeq HD technology, extend industry-leading Oncomine menu and enable panel design customization CARLSBAD, Calif., Jan. 8, 2018 /PRNewswire/ — Thermo Fisher Scientific has expanded... Read more

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes Oncomine Myeloid Research Assay leverages Thermo Fisher’s next-generation sequencing to analyze 74 genes in a single panel and overcome hurdles of sequential-based clinical research CARLSBAD, Calif., Dec. 7, 2017 /PRNewswire/ — Clinical researchers interested in studying driver mutations suspected... Read more

Shimadzu, Fujitsu, and Fujitsu Laboratories Announce Results of Collaborative Research On the Path to Utilize AI in the Processing of Mass Spectrometry Measurement Data

Shimadzu Corporation, Fujitsu Limited, and Fujitsu Laboratories Ltd. are undertaking collaborative research*1 to develop technology that utilizes AI (artificial intelligence) to process the vast amounts of data used in analyzing the measurement results, which are essential to analytical processes, acquired from Shimadzu mass spectrometers. Fujitsu, an information and communication technology company, has been exploring the... Read more

Shimadzu Promotes the Creation of Products Using Key Technologies Through Joint Research and Development Innovation Centre in Singapore in Operation

Shimadzu is promoting joint research and development with universities, research institutes, and companies with innovative technologies. As Shimadzu’s sales for its main analytical and measuring instruments business have been more extensive in countries outside Japan, it is important to quickly develop products and application systems that meet local needs and satisfy latent needs. Based on... Read more

Shimadzu Promotes the Creation of Products Using Key Technologies Through Joint Research and Development Innovation Centre in Singapore in Operation

Shimadzu is promoting joint research and development with universities, research institutes, and companies with innovative technologies. As Shimadzu’s sales for its main analytical and measuring instruments business have been more extensive in countries outside Japan, it is important to quickly develop products and application systems that meet local needs and satisfy latent needs. Based on... Read more

QIAGEN’s GeneReader NGS System delivers accuracy and ease of use for clinical research in oncology

Hilden, Germany, and Germantown, Maryland, November 14, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and ease of use of the GeneReader NGS System, the world’s first complete Sample to Insight solution for next-generation sequencing. The studies are being presented this week at the... Read more

Agilent Thought Leader Award Presented to Renowned Drug Discovery Researcher Professor Jiandong Jiang

Agilent Thought Leader Award Presented to Renowned Drug Discovery Researcher Professor Jiandong Jiang Award to Chinese Scientist Supports the Use of Various Molecular Approaches to Cancer Research SANTA CLARA, Calif., November 12, 2017 Agilent Technologies Inc. (NYSE: A) today announced that Professor Jiandong Jiang has received an Agilent Thought Leader Award in support of his... Read more